Heartland Institute for Clinical and Translational Research
Heartland Institute for Clinical and Translational Research
批准号:
8473932
负责人:
Richard J. Barohn
金额:
$310.84万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2016-02-29
关键词:
AddressCenters of Research ExcellenceCitiesClinicalClinical ResearchCommunitiesDevicesEducationFacultyFundingGoalsGrantHealthHealthcareHome environmentHumanInstitutesInstitutionInstructionKansasLaboratoriesMarshalPharmaceutical PreparationsProgram DevelopmentResearchResearch InfrastructureResearch PersonnelResourcesRuralScientistTestingTraining ProgramsTraining and InfrastructureTranslational ResearchUniversitiesVisionbasebench to bedsideimplementation researchimprovedinnovationnovelpoint of careprocessing speedprogramsresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The University of Kansas Heartland Institute for Clinical and Translational Research (HICTR) was
established in 2007 in response to the national CTSA initiative. The vision of the HICTR is to improve the
health of Kansans by creating a novel and transformative translational research enterprise from bench to
bedside to community. Particular strengths of our HICTR program are an entrepreneurial drug and device
discovery and development program and a well-developed and highly accomplished community-based
research program. The specific aims of the HICTR are to: 1) create a new academic home with innovative
training programs for clinical and translational Investigators; 2) provide an enhanced coordinated
translational research infrastructure; and 3) actively engage the community in developing, testing, and
disseminating research, by capitalizing on and expanding existing networks, to improve the health of all
Kansans¿especially those in rural, underserved and other target communities. The proposed infrastructure
and educational programs of the HICTR will address the challenges facing clinical and translational
investigators by enhancing and integrating existing resources for easier access, developing new innovative
resources, and capitalizing on resources residing in research centers across the university¿including our KINBRE
and five COBRE grants~and our HICTR network institutions. In support of our aims, we have
marshaled an impressive array of institutional, corporate, and community resources in planning, developing,
and establishing the HICTR. The HICTR will provide new infrastructure and training and educational
programs to support investigators' clinical and translational research¿taking laboratory discoveries to first
trials in humans (Tl research) and moving research through to studies on dissemination and implementation
of research findings to practice (T2 research). With extraordinary institutional and community support, we
already have made tremendous progress. Funding from the CTSA program will allow the University of
Kansas' HICTR the opportunity to fully realize its potential not only for our region, but also to contribute to the
national CTSA Consortium.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Frontiers: University of Kansas Clinical and Translational Science Institute
-
批准号:9560956
-
项目类别:
-
资助金额:$402.38万
-
财政年份:2017
-
负责人:Richard J. Barohn
-
依托单位:
Frontiers: University of Kansas Clinical and Translational Science Institute
-
批准号:9514338
-
项目类别:
-
资助金额:$406.37万
-
财政年份:2017
-
负责人:Richard J. Barohn
-
依托单位:
Models of Neuromuscular Disease Across the Lifespan
-
批准号:9195818
-
项目类别:
-
资助金额:$1.6万
-
财政年份:2016
-
负责人:Richard J. Barohn
-
依托单位:
A Phase II Trial of Rituximab In Myasthenia Gravis
-
批准号:8644497
-
项目类别:
-
资助金额:$130.54万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8569903
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
A Phase II Trial of Rituximab In Myasthenia Gravis
-
批准号:8731286
-
项目类别:
-
资助金额:$105.9万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8683099
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:9341908
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:10242456
-
项目类别:
-
资助金额:$10.58万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8355588
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8543461
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:9132606
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8270452
-
项目类别:
-
资助金额:$319.78万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8365250
-
项目类别:
-
资助金额:$9.57万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8365247
-
项目类别:
-
资助金额:$185.55万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Unit for Neuroscience Trials
-
批准号:8242137
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH
-
批准号:8365246
-
项目类别:
-
资助金额:$83.5万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Unit for Neuroscience Trials
-
批准号:8337820
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8262012
-
项目类别:
-
资助金额:$13.17万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8473972
-
项目类别:
-
资助金额:$60.07万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位: